 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 2151 | 回復(fù): 7 | ||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | ||
sophia-yxh銅蟲 (正式寫手)
|
[求助]
這樣的審稿意見，我是修改再投還是換雜志呢？請(qǐng)大家評(píng)評(píng)
|
|
|
意見如下： Reviewer: 1 Comments to the Author In this paper, Yu et al. demonstrated that leonurine could protect PC12 cells from Na2S2O4- and glucose deprivation-induced apoptosis. The authors found that leonurine reduced Na2S2O4- and glucose deprivation-induced ROS production and restored the loss of mitochondria membrane potential. They also found that leonurine increased VEGF, Ras and Raf expression. The findings are of potential significance. Nevertheless, several issues preclude the acceptance of authors' work for publication in JPP at this stage. Major comments: 1. The manuscript is full of typo-grammatical mistakes. 2. The author did not explain why they chose PC12 cells as the cell model and Na2S2O4 as hypoxia-inducing agent. 3. The author did not explain why the protein levels of Ras and Raf were increased after leonurine treatment. VEGF is supposed to increase the activity but not the protein levels of Ras and Raf. 4. The author did not demonstrate that leonurine actually protected PC12 cells from apoptosis "through" VEGF/Ras/Raf/Erk pathway as described in the title. The authors should neutralize VEGF with antibody and determine if such manipulation could affect the protective effect of leonurine. Minor comments: 1. “OGD” is not a standard abbreviation and shall be fully spelled out in the title Reviewer: 2 Comments to the Author Manuscript Id: JPP-13-0647 Manuscript Title: Leonurine protects OGD-induced PC12 cells apoptosis through activation of VEGF/Ras/Raf/Erk signaling pathway. The current manuscript by Yu et al the showed the protective role of Leonurine against OGD induced PC12 cells apoptosis through activation of signaling pathway. However there are major concerns:- Authors mainly focussed to antiapoptotic activity of Leonurine. On the hand authors themselves mentioned in introduction section that leonurine, was reported to have cardioprotective and neuroprotective effect via increasing the antioxidantive and antiapoptotic effects. What difference this manuscript offer for readers? Authors used in vitro setup to show Leonurine effects and concluded that it might be applied as a potential therapeutic drug for ischemic injury treatment in abstract section. Is it justified to extrapolate in vitro preliminary results? Can leonurine cross BBB? Authors used vitamin E as positive control in some experiments but did not used for mechanistic studies though Vitamin E has reported to upregulate VEGF and other HIF-1 dependent genes in previous studies. Why authors used variable dose(s) of LN in different experiments. In Annexin why authors choosed only 25 uM and then again for caspase-3 author authors used 12.5 and 25 uM and for western blot 25 uM? Signalling pathway data has been not explained properly in result as well as discussion section which is supposed to be strength of manuscript. Minor comments:- References are not uniform, please check for format. Check for speling mistakes, typographical mistakes and please check for overall English. (Page 5:- 4th paragraph photoes spelling;Page 6 2nd paragraph Annexin ...kit was using to assess...Page 7 under result section 7th line was used is coming twice, 13th line showed no significant between..... Page 8 line 16; authors used only one concentration 25 uM but they mention concentration dependent manner? Date Sent: 28-Oct-2013 |
回復(fù)此樓» 猜你喜歡
293求調(diào)劑
已經(jīng)有14人回復(fù)
-
0703化學(xué)336分求調(diào)劑
已經(jīng)有6人回復(fù)
-
304求調(diào)劑
已經(jīng)有9人回復(fù)
-
281求調(diào)劑（0805）
已經(jīng)有8人回復(fù)
-
環(huán)境領(lǐng)域全國(guó)重點(diǎn)實(shí)驗(yàn)室招收博士1-2名
已經(jīng)有3人回復(fù)
-
材料專碩306英一數(shù)二
已經(jīng)有10人回復(fù)
-
301求調(diào)劑
已經(jīng)有6人回復(fù)
-
一志愿天津大學(xué)化學(xué)工藝專業(yè)（081702）315分求調(diào)劑
已經(jīng)有7人回復(fù)
-
302求調(diào)劑
已經(jīng)有6人回復(fù)
-
26博士申請(qǐng)
已經(jīng)有3人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 給一個(gè)雜志審稿截止的時(shí)間超過了，怎么給編輯發(fā)郵件說對(duì)不起呢？
已經(jīng)有7人回復(fù)
- 請(qǐng)問大家，做MD方向的一篇小論文，有什么審稿較快，容易中的SCI雜志么？
已經(jīng)有16人回復(fù)
- 麻煩大家介紹個(gè)審稿周期快的關(guān)于植物生理、分子生物學(xué)方面的SCI雜志
已經(jīng)有6人回復(fù)
- OL投稿，審稿人超時(shí)一倍沒反應(yīng)，該提醒雜志嗎？
已經(jīng)有18人回復(fù)
- 請(qǐng)問如何成為雜志的審稿人？
已經(jīng)有35人回復(fù)
- 我這樣反駁雜志審稿人說我是抄襲，大家看怎么樣？
已經(jīng)有20人回復(fù)
- 某SCI雜志邀我做審稿人，要不要審稿？
已經(jīng)有46人回復(fù)
- 請(qǐng)大家推薦一個(gè)審稿周期較快的SCI雜志，關(guān)于農(nóng)業(yè)遙感方向
已經(jīng)有4人回復(fù)
- RSC的雜志，拒稿重投（reject and resubmssion）還需要回復(fù)審稿人意見嗎？
已經(jīng)有6人回復(fù)
- 論文審稿回來，3個(gè)審稿人，已經(jīng)修改提交了。不知道結(jié)果如何？大家評(píng)評(píng)
已經(jīng)有33人回復(fù)
- 求助：投了RSC雜志的EES，審稿結(jié)束后編輯直接給轉(zhuǎn)投到別的雜志了
已經(jīng)有4人回復(fù)
- 投英文雜志審稿意見居然是中文�。。�！
已經(jīng)有65人回復(fù)
- 請(qǐng)問Philosophical magazine letters雜志怎樣？
已經(jīng)有3人回復(fù)
- 請(qǐng)問大家知道elsevier出版的雜志measurement是否收審稿費(fèi)和版面費(fèi)��？
已經(jīng)有11人回復(fù)
sophia-yxh
銅蟲 (正式寫手)
- 應(yīng)助: 3 (幼兒園)
- 金幣: 329.2
- 散金: 488
- 紅花: 10
- 帖子: 528
- 在線: 245.2小時(shí)
- 蟲號(hào): 1358919
- 注冊(cè): 2011-08-02
- 性別: MM
- 專業(yè): 藥理學(xué)其他科學(xué)問題
4樓2013-11-04 21:49:11
RXMCDM
版主 (文壇精英)
- 應(yīng)助: 401 (碩士)
- 貴賓: 1.908
- 金幣: 38947.6
- 散金: 4908
- 紅花: 88
- 沙發(fā): 4
- 帖子: 11453
- 在線: 1355.6小時(shí)
- 蟲號(hào): 2739168
- 注冊(cè): 2013-10-20
- 性別: GG
- 專業(yè): 一般管理理論與研究方法論
- 管轄: 論文翻譯
2樓2013-11-04 21:40:44
山海一色
木蟲 (著名寫手)
- 應(yīng)助: 211 (大學(xué)生)
- 金幣: 3220.7
- 散金: 341
- 紅花: 36
- 帖子: 1537
- 在線: 385.2小時(shí)
- 蟲號(hào): 2625949
- 注冊(cè): 2013-08-31
- 性別: GG
- 專業(yè): 控制論中的數(shù)學(xué)方法
3樓2013-11-04 21:47:11
山海一色
木蟲 (著名寫手)
- 應(yīng)助: 211 (大學(xué)生)
- 金幣: 3220.7
- 散金: 341
- 紅花: 36
- 帖子: 1537
- 在線: 385.2小時(shí)
- 蟲號(hào): 2625949
- 注冊(cè): 2013-08-31
- 性別: GG
- 專業(yè): 控制論中的數(shù)學(xué)方法
5樓2013-11-04 21:56:45
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料專碩306英一數(shù)二 +8 | z1z2z3879 2026-03-16 | 10/500 |
|
|---|---|---|---|---|
|
[考研] 311求調(diào)劑 +9 | 冬十三 2026-03-15 | 10/500 |
|
|
|
[考研] 化學(xué)工程321分求調(diào)劑 +11 | 大米飯！ 2026-03-15 | 14/700 |
|
|
|
[考研] 一志愿蘇州大學(xué)材料工程（085601）專碩有科研經(jīng)歷三項(xiàng)國(guó)獎(jiǎng)兩個(gè)實(shí)用型專利一項(xiàng)省級(jí)立項(xiàng) +6 | 大火山小火山 2026-03-16 | 8/400 |
|
|
|
[考研] 一志愿南京大學(xué)，080500材料科學(xué)與工程，調(diào)劑 +4 | Jy? 2026-03-16 | 4/200 |
|
|
|
[考研] 藥學(xué)383 求調(diào)劑 +3 | 藥學(xué)chy 2026-03-15 | 4/200 |
|
|
|
[考研] 0854控制工程 359求調(diào)劑 可跨專業(yè) +3 | 626776879 2026-03-14 | 9/450 |
|
|
|
[考研] 304求調(diào)劑 +3 | 曼殊2266 2026-03-14 | 3/150 |
|
|
|
[考研] 070300化學(xué)學(xué)碩求調(diào)劑 +6 | 太想進(jìn)步了0608 2026-03-16 | 6/300 |
|
|
|
[考研] 283求調(diào)劑 +10 | 小樓。 2026-03-12 | 14/700 |
|
|
|
[考研] 085600材料與化工 求調(diào)劑 +13 | enenenhui 2026-03-13 | 14/700 |
|
|
|
[考研] 22408總分284求調(diào)劑 +3 | InAspic 2026-03-13 | 3/150 |
|
|
|
[考研] 材料與化工 323 英一+數(shù)二+物化，一志愿：哈工大 本人本科雙一流 +4 | 自由的_飛翔 2026-03-13 | 5/250 |
|
|
|
[基金申請(qǐng)] 現(xiàn)在如何回避去年的某一個(gè)專家，不知道名字 +3 | zk200107 2026-03-12 | 6/300 |
|
|
|
[考研] 297求調(diào)劑 +4 | 學(xué)海漂泊 2026-03-13 | 4/200 |
|
|
|
[考研] 330求調(diào)劑 +3 | ?醬給調(diào)劑跪了 2026-03-13 | 3/150 |
|
|
|
[考研] 材料與化工求調(diào)劑一志愿 985 總分 295 +8 | dream…… 2026-03-12 | 8/400 |
|
|
|
[考研] 301求調(diào)劑 +6 | Liyouyumairs 2026-03-11 | 6/300 |
|
|
|
[考研] 290求調(diào)劑 +7 | ADT 2026-03-12 | 7/350 |
|
|
|
[論文投稿]
投稿問題
 5+4
|
星光燦爛xt 2026-03-12 | 6/300 |
|